Corporate News     04-Dec-19
ERIS Lifesciences acquires Zomelis' and its associated trademarks from Novartis AG
For consideration of USD 13 million
ERIS Lifesciences has acquired trademark ‘Zomelis' and its associated trademarks from Novartis AG, based at Basel Switzerland for Indian pharmaceuticals market with effect from 10 December 2019. The consideration involved in this trademark acquisition is USD 13 million.
Previous News
  ERIS Lifesciences standalone net profit rises 15.85% in the June 2023 quarter
 ( Results - Announcements 07-Aug-23   13:44 )
  ERIS Lifesciences consolidated net profit rises 0.30% in the June 2023 quarter
 ( Results - Announcements 07-Aug-23   13:45 )
  Volumes jump at ERIS Lifesciences Ltd counter
 ( Hot Pursuit - 31-Jan-24   11:00 )
  Eris Life to acquire 9 dermatology brands from DRL
 ( Hot Pursuit - 16-Mar-23   14:40 )
  Eris Lifesciences fixes record date for interim dividend
 ( Market Beat - Reports 04-Aug-20   15:00 )
  ERIS Lifesciences consolidated net profit rises 21.29% in the March 2021 quarter
 ( Results - Announcements 13-May-21   16:06 )
  Omaxe Ltd leads losers in 'A' group
 ( Hot Pursuit - 04-Aug-20   15:00 )
  Eris Lifesciences allots 82,841 equity shares under ESOP
 ( Corporate News - 13-Jul-21   17:40 )
  Eris Lifesciences IPO Subscribed 3.25 times
 ( IPO Centre - IPO News 20-Jun-17   16:46 )
  ERIS Lifesciences schedules AGM
 ( Corporate News - 16-Jun-22   17:40 )
  ERIS Lifesciences to table results
 ( Corporate News - 15-May-19   12:27 )
Other Stories
  GAIL (India) signs MoU with AM Green
  04-Oct-24   19:27
  EaseMyTrip.com resumes bookings to the Maldives
  04-Oct-24   19:25
  BLS completes acquisition of Dubai-based Citizenship Invest
  04-Oct-24   19:23
  Insecticides India launches new maize herbicide 'Torry Super'
  04-Oct-24   19:21
  Landmark Cars receives LoI from Mercedes-Benz India
  04-Oct-24   19:19
  Astra Microwave Products receives affirmation in credit ratings from CRISIL
  04-Oct-24   19:16
  Supreme Petrochem receives affirmation in credit ratings
  04-Oct-24   19:10
  Astec LifeSciences director resigns
  04-Oct-24   19:08
  Board of Gravita India approves change in directorate
  04-Oct-24   19:05
  Board of Gravita India approves fund raising up to Rs 1,000 cr
  04-Oct-24   19:03
Back Top